Back to Capital Research Global Investors Capital Research Global Investors

CVSCVS
Showing 8 of 21 quarters

Position history for Capital Research Global InvestorsCapital Research Global Investors's holdings in CVS HEALTH CORP

Capital Research Global Investors holds 24.3M shares of CVS (CVS HEALTH CORP), worth $2.5B as of 2026-Q2. The position was increased (+21.6% shares). CVS represents 0.4% of Capital Research Global Investors's portfolio.

Current Value

$2.5B

Current Shares

24.3M

Total Value Change

+$2.2B

Total Shares Change

+18.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
24.3M
+21.6%
$2.5B0.4%$102.81
46
2026-Q1
Increased
20M
+66.2%
$1.4B0.2%$70.76
56
2025-Q4
Increased
12M
+5.0%
$955.8M0.2%$77.55
40
2025-Q3
Increased
11.5M
+24.4%
$864.7M0.2%$73.07
46
2025-Q2
Decreased
9.2M
-50.8%
$635.7M0.1%$66.14
0
2025-Q1
Increased
18.7M
+647.4%
$1.3B0.3%$64.29
62
2024-Q4
Decreased
2.5M
-55.6%
$112.5M0.0%$42.07
0
2024-Q3
Decreased
5.6M
-84.1%
$354.9M0.1%$58.27
0

Other major holders of CVS: BNP PARIBAS FINANCIAL MARKETS, Steward Partners Investment Advisory, LLC, BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used